FBT | First Trust NYSE Arca Biotechnology Index FundAMEXETF golden cross and death cross projections, cross tests and history

$276.08
+$2.19 (+0.80%)

First Trust NYSE Arca Biotechnology Index Fund (FBT) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $276.08 vs 50 $269.27 / 200 $233.60
Projection
No cross projected
Test
No active test
Last cross
Golden cross 5 Sep 2025 ยท projected 16 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $278.55 vs 50 $229.15 / 200 $177.79
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 14 Oct 2024 ยท projected 18 bars out ยท tested 1 bar

4-hour as of 3 Nov 16:00 ET

Price
above both $276.08 vs 50 $269.40 / 200 $259.09
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 May 2026 bar 2 ยท projected 14 bars out ยท tested 5 bars

Cross history

26
crosses on record since 2018
13 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
13 May 2026Golden4-hour14 bars out5 bar cross test
12 Mar 2026Death4-hour25 bars outNot tested
5 Sep 2025Golden steepdaily16 bars outNot tested
16 Jul 2025Golden4-hour22 bars outโ€”
15 Apr 2025Death moderatedaily19 bars outNot tested

About FBT

ExchangeAMEX
InstrumentETF
Median $ volume, 60 d$11.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2018

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.